Literature DB >> 20823875

A cancer fate in the hands of a samurai.

Malcolm A S Moore.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20823875     DOI： 10.1038/nm0910-963

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  12 in total

1.  An RNAi screen identifies Msi2 and Prox1 as having opposite roles in the regulation of hematopoietic stem cell activity.

Authors:  Kristin J Hope; Sonia Cellot; Stephen B Ting; Tara MacRae; Nadine Mayotte; Norman N Iscove; Guy Sauvageau
Journal:  Cell Stem Cell       Date:  2010-07-02       Impact factor: 24.633

2.  Enforced expression of NUP98-HOXA9 in human CD34(+) cells enhances stem cell proliferation.

Authors:  Ki Y Chung; Giovanni Morrone; Jan Jacob Schuringa; Magdalena Plasilova; Jae-Hung Shieh; Yue Zhang; Pengbo Zhou; Malcolm A S Moore
Journal:  Cancer Res       Date:  2006-12-15       Impact factor: 12.701

3.  Functional network reconstruction reveals somatic stemness genetic maps and dedifferentiation-like transcriptome reprogramming induced by GATA2.

Authors:  Tse-Shun Huang; Jui-Yu Hsieh; Yu-Hsuan Wu; Chih-Hung Jen; Yang-Hwei Tsuang; Shih-Hwa Chiou; Jukka Partanen; Heidi Anderson; Taina Jaatinen; Yau-Hua Yu; Hsei-Wei Wang
Journal:  Stem Cells       Date:  2008-02-28       Impact factor: 6.277

4.  Persistent transactivation by meis1 replaces hox function in myeloid leukemogenesis models: evidence for co-occupancy of meis1-pbx and hox-pbx complexes on promoters of leukemia-associated genes.

Authors:  Gang G Wang; Martina P Pasillas; Mark P Kamps
Journal:  Mol Cell Biol       Date:  2006-05       Impact factor: 4.272

Review 5.  Function of RNA-binding protein Musashi-1 in stem cells.

Authors:  Hideyuki Okano; Hironori Kawahara; Masako Toriya; Keio Nakao; Shinsuke Shibata; Takao Imai
Journal:  Exp Cell Res       Date:  2005-03-24       Impact factor: 3.905

6.  Musashi-2 regulates normal hematopoiesis and promotes aggressive myeloid leukemia.

Authors:  Michael G Kharas; Christopher J Lengner; Fatima Al-Shahrour; Lars Bullinger; Brian Ball; Samir Zaidi; Kelly Morgan; Winnie Tam; Mahnaz Paktinat; Rachel Okabe; Maricel Gozo; William Einhorn; Steven W Lane; Claudia Scholl; Stefan Fröhling; Mark Fleming; Benjamin L Ebert; D Gary Gilliland; Rudolf Jaenisch; George Q Daley
Journal:  Nat Med       Date:  2010-07-08       Impact factor: 53.440

7.  EVI1 overexpression in t(3;17) positive myeloid malignancies results from juxtaposition of EVI1 to the MSI2 locus at 17q22.

Authors:  An De Weer; Frank Speleman; Barbara Cauwelier; Nadine Van Roy; Nurten Yigit; Bruno Verhasselt; Barbara De Moerloose; Yves Benoit; Lucien Noens; Dominik Selleslag; Eric Lippert; Stephanie Struski; Christian Bastard; Anne De Paepe; Peter Vandenberghe; Anne Hagemeijer; Nicole Dastugue; Bruce Poppe
Journal:  Haematologica       Date:  2008-09-24       Impact factor: 9.941

8.  Musashi, a neural RNA-binding protein required for Drosophila adult external sensory organ development.

Authors:  M Nakamura; H Okano; J A Blendy; C Montell
Journal:  Neuron       Date:  1994-07       Impact factor: 17.173

Review 9.  NUP98 dysregulation in myeloid leukemogenesis.

Authors:  M A S Moore; K Y Chung; M Plasilova; J J Schuringa; J-H Shieh; P Zhou; G Morrone
Journal:  Ann N Y Acad Sci       Date:  2007-04-18       Impact factor: 5.691

10.  Regulation of myeloid leukaemia by the cell-fate determinant Musashi.

Authors:  Takahiro Ito; Hyog Young Kwon; Bryan Zimdahl; Kendra L Congdon; Jordan Blum; William E Lento; Chen Zhao; Anand Lagoo; Gareth Gerrard; Letizia Foroni; John Goldman; Harriet Goh; Soo-Hyun Kim; Dong-Wook Kim; Charles Chuah; Vivian G Oehler; Jerald P Radich; Craig T Jordan; Tannishtha Reya
Journal:  Nature       Date:  2010-07-18       Impact factor: 49.962
View more
  7 in total

1.  Ringo/cyclin-dependent kinase and mitogen-activated protein kinase signaling pathways regulate the activity of the cell fate determinant Musashi to promote cell cycle re-entry in Xenopus oocytes.

Authors:  Karthik Arumugam; Melanie C MacNicol; Yiying Wang; Chad E Cragle; Alan J Tackett; Linda L Hardy; Angus M MacNicol
Journal:  J Biol Chem       Date:  2012-01-03       Impact factor: 5.157

Review 2.  Advances and challenges in the molecular biology and treatment of glioblastoma-is there any hope for the future?

Authors:  Ignacio Veliz; Yong Loo; Omar Castillo; Niki Karachaliou; Olga Nigro; Rafael Rosell
Journal:  Ann Transl Med       Date:  2015-01

3.  Tissue-specific control of brain-enriched miR-7 biogenesis.

Authors:  Nila Roy Choudhury; Flavia de Lima Alves; Luisa de Andrés-Aguayo; Thomas Graf; Javier F Cáceres; Juri Rappsilber; Gracjan Michlewski
Journal:  Genes Dev       Date:  2013-01-01       Impact factor: 11.361

Review 4.  Drosophila as a model for context-dependent tumorigenesis.

Authors:  Marla Tipping; Norbert Perrimon
Journal:  J Cell Physiol       Date:  2014-01       Impact factor: 6.384

Review 5.  Functional Integration of mRNA Translational Control Programs.

Authors:  Melanie C MacNicol; Chad E Cragle; Karthik Arumugam; Bruno Fosso; Graziano Pesole; Angus M MacNicol
Journal:  Biomolecules       Date:  2015-07-21

6.  Mapping genomic and transcriptomic alterations spatially in epithelial cells adjacent to human breast carcinoma.

Authors:  Moustafa Abdalla; Danh Tran-Thanh; Juan Moreno; Vladimir Iakovlev; Ranju Nair; Nisha Kanwar; Mohamed Abdalla; Jennifer P Y Lee; Jennifer Yin Yee Kwan; Thomas R Cawthorn; Keisha Warren; Nona Arneson; Dong-Yu Wang; Natalie S Fox; Bruce J Youngson; Naomi A Miller; Alexandra M Easson; David McCready; Wey L Leong; Paul C Boutros; Susan J Done
Journal:  Nat Commun       Date:  2017-11-01       Impact factor: 14.919

Review 7.  Signaling pathways involved in chronic myeloid leukemia pathogenesis: The importance of targeting Musashi2-Numb signaling to eradicate leukemia stem cells.

Authors:  Foruzan Moradi; Sadegh Babashah; Majid Sadeghizadeh; Arsalan Jalili; Abbas Hajifathali; Hajifathali Roshandel
Journal:  Iran J Basic Med Sci       Date:  2019-06       Impact factor: 2.699
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.